BOTOX® Cosmetic Will Provide 250 Entrepreneurs with Access to New Resources and Opportunities and Will Award 20 Grants Worth $20,000 Each to Support Business Goals. By 2030, BOTOX® Cosmetic Pledges to Empower 50,000 Entrepreneurs, Helping to Close the Confidence Gap. IRVINE, Calif., May 1, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced BOTOX® Cosmetic's continued commitment to closing the Confidence Gap with the introduction of The Confidence Project: Empowering W ...

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). Shareholders who purchased shares of ABBV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cerevel-therapeutics-holdings-inc-loss-submission-form/?id=146202 ...

NEW YORK, May 1, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV).Shareholders who purchased shares of ABBV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/cerevel-therapeutics-holdings-inc-loss-submission-form/?id=146171&from=4  ...

Analyst's Disclosure: I/we have a beneficial long position in the shares of ABBV, JNJ, ROP, HRL, O, LOW, NEE, PEP, TROW, WST either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation ...

文章核心观点 - 律所Levi & Korsinsky通知Cerevel Therapeutics Holdings投资者有关该公司的证券集体诉讼 [1] 诉讼相关信息 诉讼类别定义 - 诉讼旨在代表受证券欺诈不利影响的Cerevel Therapeutics Holdings投资者挽回损失 [2] - 涵盖2023年10月11日至2024年8月1日期间出售或处置Cerevel公开交易普通股的人或实体 [2] - 包括截至2024年1月8日记录日期持有Cerevel股份并有权对Cerevel与AbbVie合并进行投票的人或实体 [2] - 涉及2023年10月16日左右与Bain Capital购买股份同时出售Cerevel股票的人或实体 [2] 案件详情 - Cerevel 2023年10月16日二次股票发行文件及其他公开声明遗漏AbbVie以远超每股22.81美元发行价收购Cerevel的重大事实，人为压低股价直至合并宣布 [3] - 控股股东Bain Capital在掌握AbbVie收购意向的重大非公开信息情况下，以人为压低价格从10月发行中收购Cerevel股份 [3] - 2023年12月6日Cerevel宣布AbbVie以每股45美元收购，Bain因此获利超1.2亿美元 [3] - Cerevel 2024年1月18日代理声明在AbbVie对Cerevel兴趣的真实性质和时间上误导投资者 [3] 后续安排 - 若在相关时间段内遭受损失，投资者需在2025年6月3日前申请被法院指定为首席原告，不担任首席原告也可参与赔偿分配 [4] 律所优势 - Levi & Korsinsky过去20年为受害股东争取数亿美元赔偿，在复杂证券诉讼方面经验丰富 [5] - 公司有超70名员工服务客户，连续七年跻身美国证券诉讼顶级律所前50 [5] 联系方式 - 律所Levi & Korsinsky，联系人Joseph E. Levi和Ed Korsinsky [6] - 地址为纽约市白厅街33号17楼，邮编10004 [6] - 邮箱jlevi@levikorsinsky.com，电话(212) 363 - 7500，传真(212) 363 - 7171，网址www.zlk.com [6]

AbbVie Inc. ABBV is trading higher Tuesday. The stock has been in an uptrend. In the past week, it has gained more than 12%.But now it is overbought. This could draw sellers into the market and they could pressure AbbVie lower. Benzinga’s team of technical analysts has made it the Stock of the Day.Overbought refers to the momentum of a stock. Most of the time it will stay in its normal or average trading range. If it is aggressively bought and gets above this range, traders will say that it is overbought.Th ...

–      RINVOQ (upadacitinib) is now the first and only oral Janus Kinase (JAK) inhibitor approved for the treatment of GCA in adults–      Also known as temporal arteritis, GCA is the most common vasculitis affecting adults in Western countries2 –      This marks the ninth approved indication for RINVOQ in the U.S., across rheumatology, gastroenterology, and dermatology1NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has app ...

NEW YORK, April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") (NYSE: ABBV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cerevel Therapeutics Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded c ...

The positive, post-earnings momentum lifting AbbVie's (ABBV 3.57%) stock price continued on Monday. The veteran healthcare company's shares booked a gain of more than 3% during the trading session. The key reason was a pair of bullish analyst notes on its business. That rise meant the stock easily beat the S&P 500 index, which could only manage a less than 0.1% gain. Still flying after first-quarter resultsOf the two notes, arguably the more impactful was the one BMO Capital's Evan David Seigerman published ...

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). Shareholders who purchased shares of ABBV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cerevel-therapeutics-holdings-inc-loss-submission-form/?id=1450 ...